In bone metastatic prostate cells, Ca2+/CaSR upregulates the expression of cyclin D1, a key component of the cell cycle, to support cancer cell growth, but this upregulation is absent in the nonskeletal metastases [123]. The gene discussed is CASR; the disease is cancer.